Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) is a sperm selection technique used in certain IVF treatment cycles involving ICSI. It uses high-magnification microscopy to examine the structural characteristics of sperm in greater detail before selecting a sperm for injection into a mature egg.
IMSI allows embryologists to assess sperm morphology at higher magnification than conventional ICSI sperm selection methods. Depending on the equipment and laboratory setup, magnification levels of approximately 6,000–7,000 times may be used to observe certain sperm structures.
IMSI has been investigated in cases involving severe male factor infertility, significant sperm morphology abnormalities, and previous unsuccessful IVF or ICSI cycles. However, current evidence does not consistently demonstrate that IMSI improves pregnancy or live birth outcomes compared with conventional ICSI.
The decision to consider IMSI should be based on individual fertility assessments, available clinical evidence, and discussion with a fertility specialist.
Allows sperm examination under high magnification
Provides a more detailed assessment of visible sperm morphology
May be considered in selected cases involving significant sperm morphology abnormalities
Has been investigated in patients with previous unsuccessful IVF or ICSI cycles
Has been studied in certain cases of severe male factor infertility
IMSI has not consistently demonstrated improved pregnancy or live birth outcomes compared with conventional ICSI. Its suitability should be discussed with a fertility specialist based on individual clinical findings.
| Feature | ICSI | IMSI |
|---|---|---|
| Sperm Selection | Conventional microscopic magnification | Higher magnification, potentially up to approximately 7,000x |
| Sperm Evaluation | Assessment of visible sperm characteristics, including morphology and motility | More detailed examination of visible sperm morphology |
| Clinical Use | Used for selected cases of male factor infertility and other clinical indications | Investigated in selected cases involving sperm morphology abnormalities or previous unsuccessful treatment |
| Evidence of Benefit | Established fertilization technique for appropriate indications | Additional improvement in pregnancy or live birth outcomes has not been consistently demonstrated |
Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) is a sperm selection technique used in certain IVF cycles involving ICSI. It uses high-magnification microscopy to examine visible sperm characteristics before selecting a sperm for injection into a mature egg.
IMSI uses higher microscopic magnification than conventional ICSI to allow a more detailed examination of sperm morphology. However, higher magnification does not confirm genetic normality or guarantee improved fertilization, pregnancy, or live birth outcomes.
IMSI has been investigated in selected cases involving significant sperm morphology abnormalities, severe male factor infertility, and previous unsuccessful IVF or ICSI cycles. It has also been studied in patients with recurrent pregnancy loss. However, evidence of improved reproductive outcomes remains insufficient, and IMSI is not routinely recommended for all patients.
IMSI involves laboratory-based sperm examination and selection before ICSI. Although it does not generally require an additional invasive procedure for the patient, the usual risks and limitations associated with IVF and ICSI still apply. Evidence regarding the additional clinical benefits and long-term outcomes of IMSI remains limited.
